Menu

Partnering for Increased Biosimilar Market Share: Alvotech Partners with Cipla Gulf

14.08.2019

Alvotech, a privately-owned biopharmaceutical company out of Reykjavik, Iceland, announced a partnership with Cipla Gulf FZ LLC for the commercialization of a biosimilar (AVT02 – an adalimumab biosimilar) in emerging markets. AVT02 is a biosimilar to AbbVie’s Humira with indications for several autoimmune diseases, such as Rheumatoid Arthritis. In...

Survey of market expectations

21.08.2019

The Central Bank of Iceland conducted its survey of market agents’ expectations during the period 12-14 August 2019. A total of 28 agents in the bond market, including banks, pension funds, mutual and investment funds, securities brokers, and licensed asset management firms were invited to participate. Responses were received from 24 market partici...

Get in touch

For further information on the benefits of establishing a business in Iceland please feel free to contact us.